Phase III of the NJMP is now in effect, bringing new measures to tackle Johne’s disease on UK dairy farms. What’s changing? Find out more.

Our fair value estimate of HKD 6.10 per share implies 2025 P/E of 13 times, 7 times EV/EBITDA and 5.5% dividend yield.